SCHEMBL6154880

SCHEMBL6154880

CN1CCC(Nc2ccc(C(N)=O)cc2)CC1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.59
FLT3 P36888 9/20 0.54
NTRK3 Q16288 5/20 0.47
NTRK2 Q16620 5/20 0.47
JAK2 O60674 1/20 0.46
JAK1 P23458 1/20 0.46
JAK3 P52333 1/20 0.46
NTRK1 P04629 4/20 0.45
ABL1 P00519 1/20 0.44
LCK P06239 1/20 0.44
CSF1R P07333 1/20 0.44
KIT P10721 1/20 0.44
BTK Q06187 1/20 0.44
ALDH1A1 P00352 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
MAPT P10636 1/20 0.44
KDM1A O60341 1/20 0.43
MAOA P21397 1/20 0.43
KDM1B Q8NB78 1/20 0.43
RCOR1 Q9UKL0 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8251202 0.86 POLB (0.61) POLBFLT3NTRK3NTRK2NTRK1
SCHEMBL14980367 0.86 POLB (0.61) POLBFLT3NTRK3NTRK2NTRK1
SCHEMBL27932778 0.85 SYK (0.48) POLBFLT3KITALDH1A1L3MBTL1
SCHEMBL23448724 0.83 LMNA (0.58) POLBFLT3NTRK3NTRK2ALDH1A1
SCHEMBL30828601 0.83 POLB (0.58) POLBFLT3NTRK3NTRK2NTRK1
SCHEMBL12828121 0.82 POLB (0.56) POLBFLT3NTRK3NTRK2NTRK1
SCHEMBL12670070 0.82 POLB (0.56) POLBFLT3NTRK3NTRK2NTRK1
SCHEMBL12998885 0.82 SYK (0.52) POLBALDH1A1L3MBTL1MAPT
SCHEMBL27193224 0.81 POLB (0.52) POLBFLT3NTRK3NTRK2JAK2
SCHEMBL29972939 0.81 POLB (0.49) POLBFLT3NTRK3NTRK2JAK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110835336-B Oxygen-containing heterocyclic substituted azole compound and application thereof 中国药科大学 2022-10-04 CN claimed
CN-110835336-B Oxygen-containing heterocyclic substituted azole compound and application thereof 中国药科大学 2022-10-04 CN disclosed
US-20050182040-A1 Benzamide derivatives DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) 2005-08-18 US disclosed
EP-1500643-A1 BENZAMIDE DERIVATIVES SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) 2005-01-26 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050182040-A1 Benzamide derivatives ROCK1, ROCK2, NHERF1 POLB 4155/4885FLT3 2536/4885NTRK3 3027/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.